GSK3B and esophageal squamous cell carcinoma: Combined with the studies above, we find that GSK3β inhibits the degradation of both β-Catenin and Snail, thus influencing many components such as ZO-1 and activities in the adherens junctions, thus resulting in stronger intercellular junctions, which also indicates the critical role of the related pathways in ESCC.